Position in PCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,513,304
-$264,575 QoQ
Shares Held
99,066
-19.4% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. PCRX ranks #21 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,513,304 | 99,066 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,777,879 | 122,915 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,308,809 | 127,852 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,718,714 | 144,304 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,567,194 | 149,255 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,586,327 | 144,319 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,902,735 | 154,073 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,427,083 | 161,268 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,562,350 | 159,467 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,371,253 | 149,598 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,024,054 | 148,905 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,329,653 | 141,123 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,611,763 | 140,049 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,595,826 | 137,119 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,040,265 | 130,543 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,963,741 | 130,922 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,324,520 | 125,635 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,930,355 | 117,012 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,644,392 | 110,427 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,120,632 | 109,297 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,557,572 | 124,548 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $8,830,989 | 125,995 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $7,520,152 | 125,671 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $7,160,893 | 119,110 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,111,468 | 135,534 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,729,708 | 141,059 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||